AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CLOBAZAM
21 registrations across 6 African markets— 15 active
Markets with CLOBAZAM
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CLOGABA 20 Tablet | 🇰🇪Kenya | MSN Laboratories Private Limited | active | May 2030 |
| CLOGABA 10 Tablet | 🇰🇪Kenya | MSN LABORATORIES PRIVATE LIMITED.. | active | May 2030 |
| CLOZYD 10 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Nov 2029 |
| CLOZURB 20 mg | 🇿🇦South Africa | KAHMA BIOTECH (Pty) Ltd | active | Aug 2029 |
| CLOZURB 10 mg | 🇿🇦South Africa | KAHMA BIOTECH (Pty) Ltd | active | Aug 2029 |
| QLOCAM 10 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Mar 2029 |
| CLOZOBY 10 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 2029 |
| CLOZOBY 20 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | unknown | Jan 2029 |
| CLOBAZAM 10 ADCO | 🇿🇦South Africa | Adcock Ingram Limited | active | Jun 2028 |
| CLOBAZAM 20 ADCO | 🇿🇦South Africa | Adcock Ingram Limited | active | Jun 2028 |
| CLOGABA 20 TABLET; ORAL | 🇿🇼Zimbabwe | MSN LABORATORIES LTD | active | Dec 2027 |
| CLOGABA 10 TABLET; ORAL | 🇿🇼Zimbabwe | MSN LABORATORIES LTD | active | Dec 2027 |
| CLOBAST 10MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | TUTINUS PHARMACEUTICALS PVT LTD | expired | Sept 2024 |
| URBANOL 20 mg CAPSULE | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | Aug 2022 |
| URBANOL 10 mg CAPSULE | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | Jul 2022 |
| URBANYL Comprimé sécable / 10 mg | 🇹🇳Tunisia | SANOFI AVENTIS PHARMA TUNISIE | expired | Aug 2021 |
| URBANYL Comprimé sécable / 10 MG | 🇹🇳Tunisia | WINTHROP PHARMA TUNISIE | expired | Oct 1993 |
| URBANOL 10 mg TABLETS | 🇿🇦South Africa | Equity Pharmaceutical (Pty) Ltd | active | Jan 1900 |
| URBANOL 5 mg CAPSULES | 🇿🇦South Africa | Equity Pharmaceutical (Pty) Ltd | active | Jan 1900 |
| URBANYL COMPRIME SECABLE | 🇲🇦Morocco | — | active | — |
| URBANYL COMPRIME SECABLE | 🇲🇦Morocco | — | active | — |
CLOBAZAM in Africa — Regulatory Overview
CLOBAZAM is registered across 6 African markets with 21 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Kenya, Morocco, Tunisia and 2 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 21 registrations, 15 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.